Group Telehealth Behavioral Cough Suppression Therapy
ConditionRefractory Chronic Cough
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Montana
About this trial
The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
At least 18 years old
Predominantly dry cough for at least 8 weeks
Evaluated and treated by at least one physician for cough
Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results
Disqualifiers
Under age 18
Coughing up blood
Current smoker of any substance
History of smoking or 10 or more years
Trial design
Design model
Single group
Treatments tested in this trial
Behavioral Treatment
BehavioralBehavioral cough suppression therapy delivered in a group setting via telehealth.
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: Group Telehealth Behavioral Cough Suppression TherapyExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Leicester Cough Questionnaire
The Leicester Cough Questionnaire is a 19-item self-report questionnaire that is valid and reliable, and repeatable every two weeks. The total possible score is 21. The higher the score the better the cough-related quality of life.
Time frame
Baseline, one-week post-treatment, and one-month post-treatmentSecondary outcomes
1
Patient Global Impression of Severity Scale in Chronic Cough
The Patient Global Impression of Severity Scale in Chronic Cough involves the patient answering the question "how do you rate your overall current cough severity?" with options of "no problem, mild, moderate, or severe problem."
Time frame
Baseline, every treatment session (4-6 treatment sessions, one treatment session per week), and one-month post-treatmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov